Robert Grant, MD
Pulmonary Disease · San Francisco, CANPI 1508891748
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pulmonary disease clinicians in CA, where the typical reported total is $1,248.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 34 payments — averaging $17,316 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$589K
How this compares
$0 in reported general payments places this provider in the 5th percentile of 1,261 pulmonary disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 143 | $118,255 |
| Spiriva RespimatTiotropium Bromide | 72 | $45,431 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 42 | $27,941 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 55 | $24,397 |
| Spiriva HandihalerTiotropium Bromide | 21 | $19,368 |
| Incruse ElliptaUmeclidinium Bromide | 24 | $7,855 |
| Atrovent HfaIpratropium Bromide | 13 | $5,911 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,211 |
| BreynaBudesonide/Formoterol Fumarate | 15 | $4,072 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $1,731 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,453 |
| Ventolin HfaAlbuterol Sulfate | 18 | $1,421 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $1,395 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $1,299 |
| Montelukast Sodium | 136 | $1,040 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in San Francisco
- Nicholas KolaitisSan Francisco$122K
- Samuel LouieSacramento$2.8M
- Shyamsunder SubramanianTracy$1.5M
- Toby MaherLos Angeles$1.3M
- Rajkumar DasguptaPasadena$930K
- Hoang leFountain Valley$814K
- Kevin FussellEncinitas$788K
- Revati ShreeniwasStanford$726K
- David PhamWestminster$571K
- Vijay BalasubramanianFresno$529K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.